
-
Tesla approves $29 bn in shares to Musk as court case rumbles on
-
Stocks rebound on US rate cut bets
-
Swiss eye 'more attractive' offer for Trump after tariff shock
-
Trump says will name new economics data official this week
-
Three things we learned from the Hungarian Grand Prix
-
Lions hooker Sheehan banned over Lynagh incident
-
Jordan sees tourism slump over Gaza war
-
China's Baidu to deploy robotaxis on rideshare app Lyft
-
Israel wants world attention on hostages held in Gaza
-
Pacific algae invade Algeria beaches, pushing humans and fish away
-
Siraj stars as India beat England by six runs in fifth-Test thriller
-
Stocks mostly rise as traders boost US rate cut bets
-
S.Africa eyes new markets after US tariffs: president
-
Trump envoy's visit will be 'important', Moscow says
-
BP makes largest oil, gas discovery in 25 years off Brazil
-
South Korea removing loudspeakers on border with North
-
Italy fines fast-fashion giant Shein for 'green' claims
-
Shares in UK banks jump after car loan court ruling
-
Beijing issues new storm warning after deadly floods
-
Most markets rise as traders US data boosts rate cut bets
-
17 heat records broken in Japan
-
Most markets rise as traders weigh tariffs, US jobs
-
Tycoon who brought F1 to Singapore pleads guilty in graft case
-
Australian police charge Chinese national with 'foreign interference'
-
Torrential rain in Taiwan kills four over past week
-
Rwanda bees being wiped out by pesticides
-
Tourism boom sparks backlash in historic heart of Athens
-
Doctors fight vaccine mistrust as Romania hit by measles outbreak
-
Fritz fights through to reach ATP Toronto Masters quarters
-
Trump confirms US envoy Witkoff to travel to Russia in coming week
-
Mighty Atom: how the A-bombs shaped Japanese arts
-
'Let's go fly a kite': Capturing wind for clean energy in Ireland
-
Pakistan beat West Indies by 13 runs to capture T20 series
-
80 years on, Korean survivors of WWII atomic bombs still suffer
-
Teenage kicks: McIntosh, 12-year-old Yu set to rule the pool at LA 2028
-
New Zealand former top cop charged over material showing child abuse and bestiality
-
Bangladesh ex-PM palace becomes revolution museum
-
South Korea begins removing loudspeakers on border with North
-
Asian markets fluctuate as traders weigh tariffs, US jobs
-
Italy's fast fashion hub becomes Chinese mafia battlefield
-
Trump confirms US envoy Witkoff to travel to Russia 'next week'
-
Australia name experienced squad for Women's Rugby World Cup
-
Netanyahu asks Red Cross for help after 'profound shock' of Gaza hostage videos
-
Dire water shortages compound hunger and displacement in Gaza
-
Philippine, Indian navies begin first joint South China Sea patrols
-
AI search pushing an already weakened media ecosystem to the brink
-
New Zealand former top cop charged over child porn, bestiality material
-
Messi out indefinitely with 'minor muscle injury': club
-
Robertson names one uncapped player in All Blacks squad
-
Swiatek crashes out of WTA Canadian Open, Osaka races through
RBGPF | 0.08% | 75 | $ | |
CMSC | 0.39% | 22.96 | $ | |
SCS | 36.63% | 16.065 | $ | |
GSK | -0.95% | 37.205 | $ | |
RIO | 0.57% | 59.99 | $ | |
NGG | 1.45% | 72.88 | $ | |
AZN | -0.42% | 73.64 | $ | |
BTI | 2.6% | 55.8 | $ | |
SCU | 0% | 12.72 | $ | |
RYCEF | 2% | 14.49 | $ | |
RELX | 0.65% | 51.93 | $ | |
BCC | -0.28% | 83.12 | $ | |
BCE | -0.66% | 23.415 | $ | |
BP | 1.5% | 32.235 | $ | |
JRI | 0.38% | 13.15 | $ | |
CMSD | 0.55% | 23.479 | $ | |
VOD | 0.77% | 11.045 | $ |

Japan biochemist who discovered statins, Akira Endo, dies
Japanese biochemist Akira Endo, who discovered cholesterol-lowering statins, has died aged 90, his former student and colleague said on Tuesday.
Statins, which can prevent heart attacks or strokes, are among the most commonly prescribed drugs worldwide.
Keiji Hasumi, a professor who was a long-time associate of Endo, said the scientist had died on June 5.
"His work was truly great. Statins didn't exist before Endo," Hasumi told AFP. "It has the same value and impact as the discovery of penicillin."
Johns Hopkins Medicine says more than 200 million people take statins. Studies say the global market for them was worth $15 billion in 2023 and is expected to grow.
Endo experimented on thousands of microbes to reach his 1973 discovery of mevastatin -- an agent derived from penicillin that reduces so-called "bad" cholesterol in the blood.
The researcher "was a tough, strict person. He was insightful and perceptive," and "able to see the hidden essence of things", Hasumi said.
Endo was born in 1933 to a farming family in rural northern Japan.
His ambitions began early thanks to his grandfather, who was interested in medicine and became a "great home teacher", Endo said in a 2008 autobiographical essay.
As a student, Endo became interested in antibiotics like penicillin, "deeply impressed" by how many lives they had saved, his essay in the journal Nature Medicine said.
Endo carried out research in New York in the late 1960s, when coronary heart disease was the main cause of US deaths.
"I often saw ambulances coming to take elderly people who had suffered a heart attack to hospital", which "made me realise the importance of developing a cholesterol-lowering drug", he said.
Endo worked at the Tokyo University of Agriculture and Technology, which issued a statement expressing condolences over his death, and at Japanese drugmaker Sankyo, now a part of Daiichi-Sankyo.
He spent two years testing 6,000 strains of microbe in the search for a new drug that could help achieve his goal before finally finding mevastatin.
Conflicting reports on the benefits and potential harms of statins in recent years have prompted some people prescribed the drugs to stop taking them.
"Are statins safe? For most people, the answer is a resounding yes, according to a 2014 Johns Hopkins meta-analysis of 20 years worth of published research," the US university says.
Endo was a strong candidate for a Nobel Prize, but never won. In a report on his death, Japanese broadcaster NHK noted Endo had received other accolades, including being honoured as a Person of Cultural Merit by the government in 2011.
His discovery "was the result of many twists and turns", Hasumi said.
"He reached his goal by overcoming so many challenges, without which medicines cannot be created, I think I remember him saying."
K.Hassan--SF-PST